Hippo Holdings, Inc. (HIPO)
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-09
$32.12-1.65%
Close 2026-09-09 · 1-day change
NYSEFinancialsInsurance - Property & CasualtySnapshot 2026-09-09
Intact: The reason to own it still holds.
Hippo raised revenue guidance to about $565 million for 2026. Net income improved from a loss to a $7.1 million profit in Q1 2026. Operating income turned positive, reaching $7.2 million in Q1 2026. The company uses AI to improve home insurance and gain market share.
If Hippo fails to keep growing revenue above $460 million, it risks stalling. Profit could fall back to losses, hurting confidence. Competition or tech issues could slow its progress.
The price is near our fair value of $28.22. Analysts expect about 33% revenue growth, which matches our view.
Breaks if: Net income falls below zero in FY26
Management focuses on improving net income and adjusted net income, with multiple quarters showing positive net income and raised adjusted net income guidance.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
HIPO represents a turnaround investment with a focus on improving revenue and net income. The current thesis is in a watch state, as recent financial performance has not yet aligned with industry peers, but there are signs of management stability and sector support.
The market appears to have priced in a justified valuation, reflecting low fragility and a modest expectations gap. HIPO's valuation is considered cheap compared to its peers, suggesting that investors may not expect significant near-term improvements.
Management is on track with priorities to increase revenue and improve net income, showing positive growth in both areas. However, operating income enhancement has mixed results, which could pose challenges in the near term.
The thesis hinges on HIPO's ability to maintain its revenue and net income growth while navigating the broader financial sector's performance. Key factors include the performance of sector bellwethers and the potential for guidance adjustments that could impact credibility.
The most important moves since the prior daily snapshot.
Valuation rose by 14.6 points (from 23.8 to 38.4).
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. Net income improved from $7.1 million in 2026-Q1 to $10.1 million in 2026-Q2. Adjusted net income guidance increased from $48 - $56 million to $62 - $70 million for full year 2026. The trajectory is delivering with positive net income growth and raised adjusted net income expectations.
“We now expect upwards of $70 million of adjusted net income for full year 2026.”
“Prior Updated 2026 FY Guidance Adjusted Net Income $48 - $56M.”
“2026 FY Guidance Adjusted Net Income $48 - $56M.”
Breaks if: Operating income falls below zero in Q1 2026
Management aims to improve operating income through underwriting performance and expense discipline, reflected in improved combined ratios and operating income growth.
Stated as a priority in 3 of last 3 quarters. Operating income improved slightly from $6.8 million in 2025-Q4 to $7.2 million in 2026-Q1 and remained stable at $7.2 million in 2026-Q2. Combined ratio guidance improved from 103%-105% to 99%-101% in 2026, reflecting better underwriting and expense management. The trajectory shows delivering progress on operating income enhancement.
“Operating income of $7.2 million for the quarter ended June 30, 2026.”
“Operating income of $7.2 million for the quarter ended March 31, 2026.”
“Operating income of $6.8 million for the quarter ended December 31, 2025.”
Breaks if: Revenue falls below $460 million in FY26
Management aims to grow revenue significantly in 2026, raising full-year revenue guidance multiple times reflecting confidence in execution.
Stated as a priority in 3 of last 3 quarters. Revenue guidance for full year 2026 increased from $560 - $570 million in 2026-Q1 to $580 - $585 million in 2026-Q2. Actual revenue grew from $121.5 million in 2026-Q1 to $144.7 million in 2026-Q2, supporting the raised guidance. The trajectory matches management's stated confidence and delivery on revenue growth.
“We now expect revenue of $580 - $585 million for full year 2026.”
“Prior Updated 2026 FY Guidance Revenue $560 - $570M.”
“2026 FY Guidance Revenue $560 - $570M.”
Over the next 1 to 3 years, HIPO's trajectory will depend on its execution of management priorities and external sector influences. Not investment advice.